ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,609Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 220

$965K Total Retail Price of All Prescriptions

Rank: 3 out of 220

560 Patients Receiving at Least One Drug in Part D
97% Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Hawaii
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 560 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 560 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LISINOPRIL 559 531 88 1 1
FUROSEMIDE 558 539 89 2 11
SIMVASTATIN 489 476 90 3 2
LOSARTAN POTASSIUM 485 480* 96 4 5
NAMENDA 459 459 49 5 28
OMEPRAZOLE 403 379 75 6 9
ATORVASTATIN CALCIUM 390 385* 79 7 3
LEVOTHYROXINE SODIUM 377 372* 61 8 6
AMLODIPINE BESYLATE 364 359* 70 9 4
DONEPEZIL HCL 355 355 59 10 30
MIRTAZAPINE 318 318 48 11 39
METFORMIN HCL 283 251 49 12 7
LACTULOSE 283 264 52 12 73
METOPROLOL TARTRATE 263 241 48 14 17
POTASSIUM CHLORIDE 250 238 52 15 29
EVISTA 237 237 36 16 48
NIFEDIPINE ER 203 198* 35 17 56
LOVASTATIN 193 193 28 18 12
METOPROLOL SUCCINATE 193 193 41 18 13
GEMFIBROZIL 189 176 30 20 79
ATENOLOL 186 186 35 21 15
CITALOPRAM HBR 181 181 29 22 53
ALENDRONATE SODIUM 179 174* 30 23 18
WARFARIN SODIUM 161 161 24 24 21
HYDROCHLOROTHIAZIDE 158 153* 33 25 10
CLOPIDOGREL 157 157 23 26 19
TAMSULOSIN HCL 155 142 28 27 22
PIOGLITAZONE HCL 142 142 17 R 28 57
PRAVASTATIN SODIUM 132 132 28 29 14
GABAPENTIN 124 111 22 30 23
LORAZEPAM 120 107 26 B 31 50
ESCITALOPRAM OXALATE 117 117 26 32 63
CARVEDILOL 115 115 26 33 24
PANTOPRAZOLE SODIUM 114 114 23 34 25
CELEBREX 112 112 16 35 43
RANITIDINE HCL 111 111 15 36 31
HYDROCODONE-ACETAMINOPHEN 109 93 34 S3 37 8
TAMIFLU 109 104* 83 37 159
ALLOPURINOL 99 99 12 39 16
TRADJENTA 97 97 17 40 140
ZOLPIDEM TARTRATE 89 73 24 41 27
PRANDIN 86 86 14 42 165
DOXYCYCLINE HYCLATE 85 80* 53 43 104
EXELON 81 <11 <11 44 94
SPIRIVA 80 <11 <11 45 58
CALCITONIN-SALMON 79 79 17 46 146
FENOFIBRATE* 78 78 11 47 69
DIOVAN 73 <11 <11 48 40
BACLOFEN 68 <11 <11 49 112
LANTUS 67 <11 <11 50 98
JANUVIA 65 <11 <11 51 35
ONGLYZA 64 64 11 52 182
LYRICA 62 <11 <11 53 89
LOSARTAN-HYDROCHLOROTHIAZIDE 62 62 14 53 20
PRADAXA 60 <11 <11 55 155
POLYETHYLENE GLYCOL 3350 55 50* 17 56 84
TRAZODONE HCL 54 <11 <11 57 52
TERAZOSIN HCL 52 <11 <11 58 77
LATANOPROST 51 <11 <11 59 214
TRAMADOL HCL 51 51 12 59 47
MUPIROCIN* 50 50 36 61 132
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.